Pocket Naloxone

Bethesda, United States Founded: 2019 • Age: 7 yrs
FDA-approved devices for opioid overdose management are developed.

About Pocket Naloxone

Pocket Naloxone is a company based in Bethesda (United States) founded in 2019 by Ashanthi Mathai and Kathryn Bowsher.. Pocket Naloxone has raised $6.16 million across 1 funding round. The company has 3 employees as of December 31, 2024. Pocket Naloxone offers products and services including NaxSwab OTC. Pocket Naloxone operates in a competitive market with competitors including Celero Systems, Synens, NIRLAB, Labb and ION-GAS, among others.

  • Headquarter Bethesda, United States
  • Employees 3 as on 31 Dec, 2024
  • Founders Ashanthi Mathai, Kathryn Bowsher
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pocket Naloxone Corp.
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.16 M (USD)

    in 1 rounds

  • Latest Funding Round
    $6.16 M (USD), Series A

    Mar 15, 2021

  • Investors
  • Employee Count
    3

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pocket Naloxone

Pocket Naloxone offers a comprehensive portfolio of products and services, including NaxSwab OTC. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Nasal swab for rapid Naloxone administration to reverse opioid overdoses.

Funding Insights of Pocket Naloxone

Pocket Naloxone has successfully raised a total of $6.16M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.16 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $6.2M
  • First Round

    (15 Mar 2021)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2021 Amount Series A - Pocket Naloxone Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Pocket Naloxone

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Pocket Naloxone

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pocket Naloxone Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pocket Naloxone

Pocket Naloxone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celero Systems, Synens, NIRLAB, Labb and ION-GAS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
An ingestible device for detecting opioid overdoses is developed.
domain founded_year HQ Location
Provider of drug abuse detection devices
domain founded_year HQ Location
Offers handheld devices for instant material composition analysis using spectroscopy.
domain founded_year HQ Location
Mobile app for efficient drug testing and rapid results via various specimen types.
domain founded_year HQ Location
Develops customized analytical devices for medical, forensic, and quality assurance applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pocket Naloxone

Frequently Asked Questions about Pocket Naloxone

When was Pocket Naloxone founded?

Pocket Naloxone was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is Pocket Naloxone located?

Pocket Naloxone is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.

Who is the current CEO of Pocket Naloxone?

Ashanthi Mathai is the current CEO of Pocket Naloxone. They have also founded this company.

Is Pocket Naloxone a funded company?

Pocket Naloxone is a funded company, having raised a total of $6.16M across 1 funding round to date. The company's 1st funding round was a Series A of $6.16M, raised on Mar 15, 2021.

How many employees does Pocket Naloxone have?

As of Dec 31, 2024, the latest employee count at Pocket Naloxone is 3.

What does Pocket Naloxone do?

Pocket Naloxone was founded in 2019 and is based in Bethesda, United States. Medical devices approved by the FDA are developed by the company for managing opioid overdoses. A platform is provided that includes Naloxone Hydrochloride, which functions as an antidote to reverse opioid effects and prevent deaths. Operations focus on healthcare solutions in the opioid crisis sector.

Who are the top competitors of Pocket Naloxone?

Pocket Naloxone's top competitors include Celero Systems, Synens and NIRLAB.

What products or services does Pocket Naloxone offer?

Pocket Naloxone offers NaxSwab OTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available